MED

Andrea B. Thomas

Known title: DirectorCIK: 0001779769

Andrea B. Thomas's purchase track record

How the stock did after each of Andrea B. Thomas's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
5
of 5 since November 8, 2022
Stock higher 6 months later
0%
3 months: 40%
Median 6-month return
-19.4%
3 months: -21.4%
Beat the S&P 500
0%
median -27.4% vs. index
PurchaseStockAmount3 months6 months
11/7/2023MED$3K-21.8%-63.0%
8/8/2023MED$3K-21.4%-38.5%
5/9/2023MED$1K+4.1%-18.1%
2/7/2023MED$1K-22.6%-19.4%
11/8/2022MED$1K+6.6%-17.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

No new news for MED in the past week. There are no recent news items specifically about Medifast Inc. in the last seven days. The only recent headlines are about Hormel Foods and Boston Beer, which do not involve Medifast. Therefore, no new developments have been reported for the company itself.

this person other insiders at MED

Transaction History

MED▲ Buy$0
MED▲ Buy$0
MED▲ Buy$0
MED▲ Buy$3K
MED▲ Buy$3K
MED▲ Buy$0
MED▲ Buy$1K
MED▲ Buy$1K
MED▲ Buy$1K
MED▲ Buy$1K
MED▲ Buy$0
MED▼ Sell$200K

We use analytics to understand how market-wall is used. No personal data is sold.